Still's Disease, Adult-Onset
Showing 1 - 25 of >10,000
Acostill ( RaDiCo Cohort) (RaDiCo Acostill)
Active, not recruiting
- Still Disease
- +2 more
-
Paris, Île-de-France, FranceRaDiCo-AcoStill
Jun 22, 2023
Still's Disease, Juvenile Onset, Still's Disease, Adult-Onset Trial in Japan (Anakinra, Placebo)
Recruiting
- Still's Disease, Juvenile Onset
- Still's Disease, Adult-Onset
- Anakinra
- Placebo
-
Chiba-shi, Chiba, Japan
- +17 more
Apr 3, 2023
Genetics, and Pathophysiology of Systemic Juvenile Idiopathic
Recruiting
- Still's Disease, Adult-Onset
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 18, 2022
Still's Disease, Adult-Onset Trial in Adelaide (APB-R3, Placebo)
Not yet recruiting
- Still's Disease, Adult-Onset
- APB-R3
- Placebo
-
Adelaide, South Australia, AustraliaCMAX Clinical Research
Jan 27, 2023
Adult Onset Still's Disease Trial in Worldwide (AEVI-007 (CERC-007, AVTX-007))
Recruiting
- Adult Onset Still's Disease
- AEVI-007 (CERC-007, AVTX-007)
-
La Mesa, California
- +13 more
Aug 26, 2022
Adult-Onset Still's Disease, AOSD Trial in Moscow, St. Petersburg (RPH-104, Placebo)
Not yet recruiting
- Adult-Onset Still's Disease
- AOSD
- RPH-104
- Placebo
-
Moscow, Russian Federation
- +3 more
Jun 21, 2022
Adult Onset Still's Disease Trial in Japan (Canakinumab)
Recruiting
- Adult Onset Still's Disease
- Canakinumab
-
Nagoya, Aichi, Japan
- +15 more
Jul 14, 2022
Macrophage Activation Syndrome, Lymphohistiocytosis, Hemophagocytic, Arthritis, Juvenile Trial in Worldwide (Emapalumab)
Completed
- Macrophage Activation Syndrome
- +3 more
-
Cincinnati, Ohio
- +4 more
May 16, 2022
Rheumatic Diseases, Adult Onset Still Disease, Ankylosing Spondylitis Trial in New Haven
Recruiting
- Rheumatic Diseases
- +19 more
-
New Haven, ConnecticutYale New Haven Hospital
Sep 30, 2021
Adult Onset Still's Disease in Chinese Population
Unknown status
- Adult Onset Still Disease
- Exon sequencing and Methylated sequencing
-
Hunan, Changsha, ChinaThe Second Xiangya Hospital of Central South University
Jan 31, 2021
Adult Onset Still Disease Classification Criteria and
Completed
- Adult Onset Still Disease
- diagnosis criteria performance
- (no location specified)
Feb 10, 2021
Still's Disease, Adult-Onset, Still's Disease, Juvenile-Onset Trial in Canada, United States (anakinra, Placebo)
Terminated
- Still's Disease, Adult-Onset
- Still's Disease, Juvenile-Onset
- anakinra
- Placebo
-
Birmingham, Alabama
- +38 more
Jun 9, 2021
Pompe Disease, Muscle Loss, Obesity Trial (Multi-ingredient supplement (PDT-MIS), Placebo (PLA))
Not yet recruiting
- Pompe Disease
- +7 more
- Multi-ingredient supplement (PDT-MIS)
- Placebo (PLA)
- (no location specified)
Nov 8, 2023
Adult-Onset Still´s Disease Trial in Germany (Canakinumab, Placebo)
Evolution of Pre Type 1 Diabetes With Adult ONset
Active, not recruiting
- Type 1 Diabetes
- Type 1 Diabetes Mellitus Maturity Onset
- High genetic risk for type 1 diabetes
- High gentic risk for Coeliac disease
-
Exeter, Devon, United KingdomNIHR Exeter Clinical Research Facility (Royal Devon University H
Aug 16, 2023
Assess Speed of Onset and Durability of Effectiveness of
Not yet recruiting
- Crohn's Disease
- (no location specified)
Jun 27, 2023
Other Disorders of Vestibular Function, Bilateral, Bilateral Vestibular Deficiency (BVD), Gentamicin Ototoxicity Trial in
Not yet recruiting
- Other Disorders of Vestibular Function, Bilateral
- +8 more
- Labyrinth Devices MVI™ Multichannel Vestibular Implant System
-
Baltimore, MarylandJohns Hopkins School of Medicine
Jan 5, 2023
Glycogen Storage Disease Type II, Pompe Disease (Late-onset) Trial in Milan (Inspiratory Muscle Training (IMT), Inspiratory
Recruiting
- Glycogen Storage Disease Type II
- Pompe Disease (Late-onset)
- Inspiratory Muscle Training (IMT)
- Inspiratory Muscle Training (IMT) + Air Stacking
-
Milan, ItalyIRCCS S. Maria Nascente - Fondazione Don Carlo Gnocchi
Jul 11, 2023
Auvergne-Rhône-Alpes-Limousin Research Database for Still's
Recruiting
- Still Disease
- children and adult with Still's disease in Auvergne-Rhône-Alpes-Limousin hospital
-
Valence, Drome, France
- +15 more
Sep 14, 2021
Macrophage Activation Syndrome, Secondary Hemophagocytic Lymphohistiocytosis, Still Disease Trial in Worldwide (Emapalumab)
Recruiting
- Macrophage Activation Syndrome
- +6 more
-
Birmingham, Alabama
- +41 more
Jan 3, 2023
Natural History of Pompe Disease
Recruiting
- Glycogen Storage Disease Type II, Adult
-
Garches, Hauts-de-Seine, FranceHôpital Raymond Poincaré
Apr 20, 2022
Pompe Disease (Late-onset) Trial in Durham (Clenbuterol, Placebos)
Withdrawn
- Pompe Disease (Late-onset)
- Clenbuterol
- Placebos
-
Durham, North CarolinaDuke University Medical Center
Aug 15, 2022
Young Pectus Excavatum Patients and Genetic Defects
Completed
- Genetic Disease
- +2 more
- Genetic analysis
-
Rotterdam, Zuid-Holland, NetherlandsErasmus Medical Center
Jul 1, 2022
Best Disease and Other Retinal Degenerative Diseases.
Active, not recruiting
- Retinal Disease
- +4 more
-
Rochester, MinnesotaMayo Clinic
Jan 4, 2022